EUVIMED · CrossrefZeitschrift
healthbook TIMES Oncology Hematology
ISSN 2673-2092 · The Heathbook company AG
Neueste Artikel
Personalizing Cancer Diagnostics and Treatments in the Era of Precision Oncology
Management of Elderly and Old Cancer Patients – Geriatric Oncology
From New Molecular Insights to New Treatment Options in Endometrial Cancer
Benefits and Complications Following First-Line Treatment with Atezolizumab plus Bevacizumab in a Patient with HCC: a Case Report
The Evolving Treatment Landscape of AML
Highlights in CAR T-Cell Therapy from ASH 2021: Potential Practice-Changing Treatments
Highlights in AL Amyloidosis from ASH 2021
Precision Oncology: Another Tower of Babel?
Training the Next Generation of Physicians – Recognizing the Importance of Women in Leadership Roles
The CAR T Cell Story
Long-Term Sustained Disease Control With Immunotherapy in Chemotherapy-Refractory Merkel Cell Carcinoma
Therapy Management of Metastatic Prostate Carcinoma in General Practice
CD19-Directed CAR T Cells Treatment in a Patient With Refractory DLBCL and CNS Involvement
Use of First-Line PARP Inhibitors in Ovarian Cancer
Genomic Testing for Advanced Prostate Cancer: Ready for Prime Time
Immunotherapy in Advanced Gastroesophageal Tumors: The Best of the Current Knowledge
First-line treatment of ALK-positive NSCLC
A Rational Sequencing of Anti-Angiogenic Agents as Second-Line Treatment Choice for mCRC Patients Progressing After a Bevacizumab-Based First Line
Response to Osimertinib in a Patient With Non-Small Cell Lung Cancer and Two Uncommon EGFR mutations
Critical Review of EGFR-Mutated NSCLC: What We Do and Do Not Know
Avenues to Precision Oncology
Neither Last nor Least: Integration of Early Palliative Care Into Standard Oncology Care
Oncofertility Approach in Females With Leukemia From the Reproductive Perspective
Precision Oncology for Hepato-Pancreato-Biliary (HPB) Cancers: State of the Art and Future Directions
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020
Precision Oncology in Gastro-Esophageal Adenocarcinoma
Molecular Diagnostic and Precision Medicine in Non-Small Cell Lung Cancer. An Update on the Treatment of the Most Important Actionable Oncogenic Driver Alterations
Breast Cancer Treatment in the Era of Precision Medicine
Folate Receptor α: A New Target for an Old Enemy?
Precision Oncology and Gender Medicine – Moving Forward, Slowly but Surely
EUVIMED